Guselkumab as a Treatment Adjunct for Pyoderma Gangrenosum While Maintaining Clinical Remission of Ulcerative Colitis

Rohan Moghe, Alex J. Mathew, David Choi, David T. Rubin

Open source

DOI
10.14309/crj.0000000000002290
Published
2026-09
Container
ACG Case Reports Journal
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.14309/crj.0000000000002290,
  title = {Guselkumab as a Treatment Adjunct for Pyoderma Gangrenosum While Maintaining Clinical Remission of Ulcerative Colitis},
  author = {Rohan Moghe and Alex J. Mathew and David Choi and David T. Rubin},
  year = {2026},
  journal = {ACG Case Reports Journal},
  doi = {10.14309/crj.0000000000002290},
  url = {https://doi.org/10.14309/crj.0000000000002290}
}

RIS

TY  - JOUR
TI  - Guselkumab as a Treatment Adjunct for Pyoderma Gangrenosum While Maintaining Clinical Remission of Ulcerative Colitis
AU  - Rohan Moghe
AU  - Alex J. Mathew
AU  - David Choi
AU  - David T. Rubin
PY  - 2026
JO  - ACG Case Reports Journal
DO  - 10.14309/crj.0000000000002290
UR  - https://doi.org/10.14309/crj.0000000000002290
ER  - 

APA

Moghe, R., Mathew, A. J., Choi, D., & Rubin, D. T. (2026). Guselkumab as a Treatment Adjunct for Pyoderma Gangrenosum While Maintaining Clinical Remission of Ulcerative Colitis. ACG Case Reports Journal. https://doi.org/10.14309/crj.0000000000002290

Source records